---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-034429"
form_type: "8-K"
ticker: "PRKR"
cik: "0000914139"
company_name: "PARKERVISION INC"
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T22:05:18.200231+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ParkerVision reports Q3 2025 net loss of $2.0M; updates on Qualcomm appeal and upcoming trials

## Summary
- Net loss $2.0M ($0.02/share) in Q3 2025 vs $10.8M ($0.12/share) in Q3 2024; improvement from lower fair-value loss on contingent payment obligations.
- Cash used in ops $4.1M in 9M 2025; cash and equivalents $0.9M at Sep 30, 2025.
- CAFC expedites Qualcomm appeal briefing Dec 2025–Feb 2026; Qualcomm moves to dismiss appeal; CAFC not yet ruled.
- Patent trials vs Realtek set Jan 12, 2026 and Apr 2026; vs MediaTek set Mar 23, 2026 in Waco, TX.
- PTAB decisions on multiple IPRs expected later this month (Nov 2025).

## SEC filing metadata
- accession: 0001437749-25-034429
- form_type: 8-K
- ticker: PRKR
- cik: 0000914139
- company_name: PARKERVISION INC
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914139/000143774925034429/0001437749-25-034429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914139/000143774925034429/prkr20250822_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-034429
- JSON: https://secwatch.observer/filing/0001437749-25-034429.json
- Plain text: https://secwatch.observer/filing/0001437749-25-034429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.